A Multi-centric Clinical Trial in China for Skin Diseases Intelligent Diagnosis and Treatment System
Launched by XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY · Jul 18, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new intelligent system to help diagnose and treat skin diseases more effectively. Researchers are using advanced imaging technology, including infrared images, to create a system that can automatically identify skin problems and assist in planning surgeries for skin tumors. The goal is to improve the accuracy and efficiency of skin disease treatment.
To participate in this trial, you need to be diagnosed with a skin disease by at least three dermatologists and require surgical treatment. You should also be able to provide informed consent and not have any life-threatening risks from the procedure. If you join the trial, you can expect to receive cutting-edge support for your skin condition, with the hope that the technology will lead to better outcomes. The trial is currently recruiting participants of all ages and genders, so if you or a loved one are interested, it may be a good opportunity to explore.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informed consented.
- • With a diagnosis of skin disease made by at least 3 dermatologists.
- • Without life-threatening risk to intervention.
- • Requires surgical treatment (For devices).
- Exclusion Criteria:
- • Having difficulties to follow-up.
- • Poor general condition.
About Xiangya Hospital Of Central South University
Xiangya Hospital of Central South University is a leading academic medical institution located in Changsha, China, renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a key affiliate of Central South University, the hospital integrates clinical practice with medical education and research, fostering an environment that promotes the development of cutting-edge therapies and treatments. With a diverse array of specialized departments and a dedicated team of healthcare professionals, Xiangya Hospital actively participates in clinical trials aimed at enhancing medical knowledge and improving patient outcomes, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Changsha, Hunan, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials